Silence Therapeutics
SLN
#7339
Rank
NZ$0.93 B
Marketcap
NZ$19.84
Share price
-3.21%
Change (1 day)
94.73%
Change (1 year)

EPS for Silence Therapeutics (SLN)

EPS in 2026 (TTM): NZ-$3.34

According to Silence Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$3.38. In 2025 the company made an earnings per share (EPS) of NZ-$3.27 a decrease over its 2024 EPS that were of NZ-$1.72.

EPS history for Silence Therapeutics from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$3.342.11%
2025NZ-$3.2790.91%
2024NZ-$1.72-32.65%
2023NZ-$2.55-5.77%
2022NZ-$2.70-13.03%
2021NZ-$3.1110.23%
2020NZ-$2.8258.5%
2019NZ-$1.782.94%
2018NZ-$1.73969.59%
2017NZ-$0.16-79.18%
2016NZ-$0.78-3.11%
2015NZ-$0.80-55%
2014NZ-$1.783.83%
2013NZ-$1.71-84.88%
2012NZ-$11.34134.19%
2011NZ-$4.84-61.8%
2010NZ-$12.67-45.65%
2009NZ-$23.32-1.16%
2008NZ-$23.594.29%
2007NZ-$22.6210.54%
2006NZ-$20.47-22.29%
2005NZ-$26.34-57.32%
2004NZ-$61.7139.1%
2003NZ-$44.3670.67%
2002NZ-$25.99-25.17%
2001NZ-$34.745.29%
2000NZ-$32.99-24.54%
1999NZ-$43.7226.7%
1998NZ-$34.51-11.73%
1997NZ-$39.0972.24%
1996NZ-$22.70